Based on this evidence, it can be hypothesized that cetuximab can contribute to reducing the cellular spread and invasion by inhibiting the HER1 promoting the EMT and endowing the stem-like phenotype of primitive tumor cells. This evidence concerns the gene EGFR and neoplasm.